Abstract 1858P
Background
Identifying the patient's discomfort and unmet needs is crucial for providing effective care. However, accurately understanding the patient's discomfort can be challenging due to various limitations in the medical field, and in some cases, their discomfort may be underestimated. To better understand the difficulties faced by cancer patients, we implemented Social Listening to identify areas where improved treatment may be provided.
Methods
From October 1, 2021 to September 30, 2022, we gathered online data related to cancer and anti-cancer treatments. Using NetBase as our social listening platform, we filtered out irrelevant and commercial content from the collected data.
Results
A total of 169,575 social mentions related to cancer and anticancer treatment were collected. Among them, 12% (n=20,899) addressed the challenges experienced by patients following a cancer diagnosis. These challenges were further categorized based on the content of social media posts, with 52% focusing on physical difficulties, 42% on emotional challenges, and 6% on difficulties related to daily life. Emotional difficulties such as worry, denial, depression, fear, and anxiety were prevalent among cancer patients, with variations in priority depending on the time of diagnosis, treatment, and post-treatment stages. Of the 16,743 social media discussions related to cancer care, only 9% were related to managing emotional stress. A majority (84%) of discussions related to mental health management involved receiving psychiatric treatment, with the remaining 16% focusing on self-help groups, communication with others, meditation, hobbies, and religious practices.
Conclusions
Emotional burdens, along with physical difficulties, were frequently discussed on social media. However, there appeared to be a relative lack of focus on the management of emotional burdens. Considering the known association between emotional management and cancer treatment outcomes, it is imperative for physicians to prioritize their patients' emotional well-being and offer appropriate support.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Korean Society of Medical Oncology.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1867P - A cross-sectional examination of information disclosure and health literacy amongst patients with lymphoma
Presenter: Steve Kalloger
Session: Poster session 05
1868P - Challenges for shared decision making in incurable cancer, with a focus on health literacy
Presenter: Chloe Holden
Session: Poster session 05
1871P - The PainRELife ecosystem: A new aid for improving clinical care and shared decision-making in breast cancer patients with chronic pain
Presenter: Marianna Masiero
Session: Poster session 05
1872P - Financial distress of a cancer disease in Germany: A new patient reported outcome measure (PROM) and first results from a bi-centered cross-sectional analysis
Presenter: Sophie Pauge
Session: Poster session 05
1873P - Patients with myeloproliferative neoplasms and self-care behaviours: Preliminary data of a cross-sectional study
Presenter: Valentina Biagioli
Session: Poster session 05
1874P - Beliefs about chemotherapy in Tunisian patients newly diagnosed with cancer
Presenter: Hadhemi Ayadi
Session: Poster session 05
1875P - Behind the use of ChatGPT for oncological purposes: Fears and challenges
Presenter: Ilaria Durosini
Session: Poster session 05
1876P - Cancer stigma: How Tunisian patients perceive their cancer
Presenter: sofiene Fendri
Session: Poster session 05
1877P - Meaning-making in the re-entry phase: A qualitative focus group study with patients with breast cancer and melanoma
Presenter: Anna Visser
Session: Poster session 05